Adherence to prescription proton pump inhibitor therapy amongst individuals diagnosed with Barrett's esophagus.

Charles E Gaber Abdullah I AbdelazizJyotirmoy SarkerJennifer L LundEvan S DellonCary C CottonSwathi EluriNicholas J Shaheen

Published in: Pharmacoepidemiology and drug safety (2024)

Using an exploratory method, we detected heterogeneity in adherence to prescription PPIs. Less than half of individuals were classified into the consistently high adherence group, suggesting that many individuals with Barrett's esophagus receive inadequate pharmacologic therapy.

Keyphrases

glycemic control
stem cells
adipose tissue
metabolic syndrome
mesenchymal stem cells
skeletal muscle
replacement therapy